ArticleESC heart failure2024

Eligibility of Asian and European registry patients for phase III trials in heart failure with reduced ejection fraction.

Yvonne Mei Fong Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.